Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3979

Epidemiology of Primary CNS Tumors in Iran: A Systematic Review  

Jazayeri, Seyed Behzad (Sina Trauma and Research Center, Tehran University of Medical Sciences)
Rahimi-Movaghar, Vafa (Sina Trauma and Research Center, Tehran University of Medical Sciences)
Shokraneh, Farhad (Research Center for Pharmaceutical Nanotechnology and Iranian Center for EBM, Tabriz University of Medical Sciences)
Saadat, Soheil (Sina Trauma and Research Center, Tehran University of Medical Sciences)
Ramezani, Rashid (Ministry of Health, Center for Disease Control and Prevention, Non-communicable Diseases Unit, Cancer Office)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3979-3985 More about this Journal
Abstract
Background: Although primary malignant CNS tumors are registered in the national cancer registry (NCR) of Iran, there are no available data on the incidence of the primary malignant or benign CNS tumors and their common histopathologies in the country. This study analyzed the 10-year data of the Iranian NCR from March 21, 2000 to March 20, 2010, including a systematic review. Materials and Methods: The international and national scientific databases were searched using the search keywords CNS, tumor, malignancy, brain, spine, neoplasm and Iran. Results: Of the 1,086 primary results, 9 papers were selected and reviewed, along with analysis of 10-year NCR data. The results showed that primary malignant brain tumors have an overall incidence of 2.74 per 100,000 person-years. The analysis of the papers revealed a benign to malignant ratio of 1.07. The most common histopathologies are meningioma, astrocytoma, glioblastoma and ependymoma. These tumors are more common in men (M/F=1.48). Primary malignant spinal cord tumors constitute 7.1% of the primary malignant CNS tumors with incidence of 0.21/100,000. Conclusions: This study shows that CNS tumors in Iran are in compliance with the pattern of CNS tumors in developing countries. The NCR must include benign lesions to understand the definitive epidemiology of primary CNS tumors in Iran.
Keywords
Benign; malignant; tumor; CNS; epidemiology; incidence; Iran;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Alimi M, Rahimi-Movaghar V (2012). Biographical sketch: Nosrat ollah ameli, mb, chb (hons), chm (birm), fics, frcs (eng). Br J Neurosurg, 26, 630-6.   DOI   ScienceOn
2 Ameli N, Hadadian A, Kamalian N (1979). Incidence of intracranial tumors in iran. Neurosurg Rev, 2, 67-71.   DOI
3 Anonymous (2000-9). Iranian annual of national cancer registry report. Annual Report of National Cancer Registry. Ministry of Health C. F. D. C. P., Noncommunicable Diseases Unit, Cancer Office. Tehran, Ministry of Health.
4 Ardehali MR (1990). Relative incidence of spinal canal tumors. Clin Neurol Neurosurg, 92, 237-43.   DOI   ScienceOn
5 Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in semnan province, iran: Results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
6 Baldi I, Gruber A, Alioum A, et al (2011). Descriptive epidemiology of cns tumors in france: Results from the gironde registry for the period 2000-2007. Neuro Oncol, 13, 1370-8.   DOI
7 Bauchet L, Rigau V, Mathieu-Daude H, et al (2007). French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol, 84, 189-99.   DOI   ScienceOn
8 Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer, 113, 1953-68.   DOI   ScienceOn
9 Cheang CM, Hwang SL, Hwong SL (1997). An analysis of intraspinal tumors in south taiwan. Kaohsiung J Med Sci, 13, 229-36.
10 Davis FG, Mccarthy BJ, Berger MS (1999). Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the united states; surveillance, epidemiology, and end results; and national cancer data base. Neuro Oncol, 1, 205-11.
11 Deltour I, Johansen C, Auvinen A, et al (2009). Time trends in brain tumor incidence rates in denmark, finland, norway, and sweden, 1974-2003. J Natl Cancer Inst, 101, 1721-4.   DOI   ScienceOn
12 Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006). Trends in brain cancer incidence and survival in the united states: Surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus, 20, 1.
13 Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917.   DOI   ScienceOn
14 Dobes M, Shadbolt B, Khurana VG, et al (2011). A multicenter study of primary brain tumor incidence in australia (2000-2008). Neuro Oncol, 13, 783-90.   DOI   ScienceOn
15 Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012). Cbtrus statistical report: Primary brain and central nervous system tumors diagnosed in the united states in 2005-2009. Neuro-Oncol, 14, 1-49.   DOI
16 Etemadi A, Sadjadi A, Semnani S, et al (2008). Cancer registry in iran: A brief overview. Arch Iran Med, 11, 577-80.
17 Habibi A (1962). Cancer in iran. Statistical data for the most frequent forms. Rev Med Moyen Orient, 19, 302-8.
18 Kaneko S, Nomura K, Yoshimura T, Yamaguchi N (2002). Trend of brain tumor incidence by histological subtypes in japan: Estimation from the brain tumor registry of japan, 1973- 1993. J Neurooncol, 60, 61-9.   DOI   ScienceOn
19 Ketabchi S,Ghodsi S (1989). A ten year review of brain tumors in tehran university of medical sciences. Tehran Medical University Journal, 47, 43-7.
20 Kurland LT, Schoenberg BS, Annegers JF, Okazaki H, Molgaard CA (1982). The incidence of primary intracranial neoplasms in rochester, minnesota, 1935-1977. Ann NY Acad Sci, 381, 6-16.   DOI
21 Larijani B, Shirzad M, Mohagheghi MA, et al (2004). Epidemiologic analysis of the tehran cancer institute data system registry (tcidsr). Asian Pac J Cancer Prev, 5, 36-9.
22 Lee CH, Jung KW, Yoo H, Park S, Lee SH (2010). Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc, 48, 145-52.   과학기술학회마을   DOI   ScienceOn
23 Manoharan N, Julka P, Rath G (2012). Descriptive epidemiology of primary brain and cns tumors in delhi, 2003-2007. Asian Pac J Cancer Prev, 13, 637-40.   과학기술학회마을   DOI   ScienceOn
24 Listed NA (1977). Esophageal cancer studies in the caspian littoral of iran: Results of population studies--a prodrome. Joint iran-international agency for research on cancer study group. J Natl Cancer Inst, 59, 1127-38.
25 Lopez-Abente G, Pollan M, Ardanaz E, Errezola M (2003). Geographical pattern of brain cancer incidence in the navarre and basque country regions of spain. Occup Environ Med, 60, 504-8.   DOI   ScienceOn
26 Mahzoni P, Mohammadizadeh F (2003). Gradings and properties of primary brain tumors of al-zahra hospital in esfahan based on who grading scale. J Lorestan Med Univ, 6, 59-64.
27 Mehrazin M, Rahmat H, Yavari P (2006). Epidemiology of primary intracranial tumors in iran, 1978-2003. Asian Pac J Cancer Prev, 7, 283-8.
28 Meshkini A, Fakhrjo A, Fathi A (2000). Prevalence of central nervous system tumors-a single center ten years study of imam khomeyni hospital of tabriz. Tabriz Medical University J, 31, 76-82.
29 Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in tehran metropolis: The first report from the tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23.
30 Moher D, Liberati A, Tetzlaff J, Altman DG (2010). Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Int J Surg, 8, 336-41.   DOI   ScienceOn
31 Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in iran. Ann Oncol, 20, 556-63.
32 Ostrom QT, Barnholtz-Sloan JS (2011). Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep, 11, 329-35.   DOI   ScienceOn
33 Seddighi A, Seddighi A, Ashrafi F, Nohehsara S (2010). Neuropsychological disorders in patients with brain tumor. Iran J Cancer Prev, 3, 42-7.
34 Pirouzmand F, Sadanand V (2007). The incidence trends of primary brain tumors in saskatchewan from 1970-2001. Can J Neurol Sci, 34, 181-6.   DOI
35 Reyhani-Kermani H (2003). An epidemiologic survey on brain tumors in kerman from 1997. Teb Jonoub J, 7, 1.
36 Rezaee O, Hadadian K (1997). A ten year review of spinal cord tumors in loghman hakim hospital. Res Med J, 24, 227-35.
37 Surawicz TS, Mccarthy BJ, Kupelian V, et al (1999). Descriptive epidemiology of primary brain and cns tumors: Results from the central brain tumor registry of the united states, 1990-1994. Neuro Oncol, 1, 14-25.
38 Wahl CJ, Tubbs RS, Spencer DD, Cohen-Gadol AA (2009). Harvey cushing as a book collector, bibliophile, and archivist: The precedence for the genesis of the brain tumor registry. Historical vignette. J Neurosurg, 111, 1091-5.   DOI   ScienceOn